Ozempic 2 MG/dose (8 MG/3 ML) 3ML
Ended Awarded Last action
- Contract number
- SPE2DR26F73PV
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $30,997
Award facts
- Contract value 100% obligated
- $30,997.02 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Ozempic 2 mg/dose (8 mg/3 mL) in 3 mL quantities under a firm fixed-price contract with a ceiling value of approximately $31,000. The contract, awarded on January 2, 2026, carries an ultimate completion date of January 5, 2026, and is classified as a non-set-aside competitive award. The place of performance is located in Conshohocken, Pennsylvania, the company's headquarters location. This delivery order represents a routine pharmaceutical procurement to support federal medical supply needs, specifically for diabetes medication distribution through the military and veteran healthcare supply chain.
This award is issued as a child contract under AmerisourceBergen Drug Corp's significantly larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. As a major pharmaceutical distributor and critical vendor for federal medical procurement, AmerisourceBergen Drug Corp leverages this comprehensive global pharmaceutical support vehicle to supply an extensive range of brand-name and generic medications, vaccines, and medical supplies across multiple therapeutic domains. The parent IDC enables the company to serve the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems worldwide, with ongoing strategic initiatives by DLA Troop Support to establish next-generation Pharmaceutical Prime Vendor Global Program contracts involving multiple regional awards.
Quick answers
Who was awarded contract SPE2DR26F73PV?
SPE2DR26F73PV was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 2, 2026.
How much is contract SPE2DR26F73PV worth?
The government has obligated $30,997 on SPE2DR26F73PV.
Is contract SPE2DR26F73PV an order under another contract?
Yes. SPE2DR26F73PV is a delivery order under SPE2DR25D1202, an indefinite delivery contract.
Was contract SPE2DR26F73PV competed?
The extent of competition for SPE2DR26F73PV was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award